GLP-1 stimulates insulin secretion, inhibits glucagon secretion, slows gastric emptying, and promotes satiety, all of which contribute to weight loss
A 10-unit draw (0.1mL) = 50mcg
(But hope springs eternal.) I enjoyed this relevant article about Professor Mike Snyder's quantified self project that just appeared in Stanford Magazine in Dec, 2021
People who experience a plateau on tirzepatide or find themselves not losing weight despite treatment sometimes consider switching from tirzepatide to semaglutide or vice versa
This widespread receptor expression suggests that GLP-1 receptor agonists may exert effects beyond glucose regulation and appetite suppression
Meaning, once you lose the weight, you should continue taking your therapeutic dose for the rest of your life